HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

7-methyl-indole ethyl isothiocyanate

structure in first source

Also Known As:

7Me-IEITC

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - 7-methyl-indole ethyl isothiocyanate: 3
Organic Chemicals: 133
- Isocyanates: 512
  - 7-methyl-indole ethyl isothiocyanate: 3

Experts

1.	Brard, Laurent: 3 articles (08/2012 - 11/2007)
2.	Singh, Rakesh K: 3 articles (08/2012 - 11/2007)
3.	Kim, Kyukwang: 2 articles (08/2012 - 11/2007)
4.	Lange, Thilo S: 2 articles (05/2008 - 11/2007)
5.	Choi, Joong Sub: 1 article (08/2012)
6.	Horan, Timothy C: 1 article (08/2012)
7.	Kristjansdottir, Katrin: 1 article (08/2012)
8.	Moore, Richard G: 1 article (08/2012)
9.	Kim, Kyu Kwang: 1 article (05/2008)
10.	Shaw, Sunil K: 1 article (05/2008)

Related Diseases

1.	Endometrial Neoplasms (Endometrial Cancer) 08/01/2012 - "7Me-IEITC demonstrated promising cytotoxic effects in endometrial cancer cell line model." 08/01/2012 - "7Me-IEITC treatment caused mitochondrial transmembrane potential reduction, elevated the production of ROS, leading to activation of apoptosis in endometrial cancer KLE and ECC-1 cells. " 08/01/2012 - "The cell viability of 7Me-IEITC treated ECC-1 and KLE endometrial cancer cell was determined by MTS assay. "
2.	Prostatic Neoplasms (Prostate Cancer) 05/01/2008 - "The viability of ovarian cancer cell lines (SKOV-3, OVCAR-3) in comparison to pancreatic and prostate cancer cell lines, primary fibroblast and immortalized trophoblasts after treatment with 7Me-IEITC was analyzed. "
3.	Ovarian Neoplasms (Ovarian Cancer) 05/01/2008 - "7Me-IEITC is a potent and growth-suppressing agent to cell lines derived from ovarian cancers by causing deactivation of survival signals, apoptosis, and cell-cycle arrest." 05/01/2008 - "The viability of ovarian cancer cell lines (SKOV-3, OVCAR-3) in comparison to pancreatic and prostate cancer cell lines, primary fibroblast and immortalized trophoblasts after treatment with 7Me-IEITC was analyzed. "
4.	Neuroblastoma 11/01/2007 - "This wide effect of 7Me-IEITC on NB cell signaling and survival suggests that it could be developed as a therapeutic agent against neuroblastoma."
5.	Neoplasms (Cancer) 08/01/2012 - "7Me-IEITC reduced the viability of the ECC-1 and KLE cancer cell-lines (IC(50)~2.5-10 μM) in a dose dependent fashion. "

Related Therapies and Procedures

1.	Aftercare (After-Treatment)